GARDASIL®

Reimbursement Tutorial

Payer Coverage and Reimbursement Issues Regarding GARDASIL®
[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]

Download Tutorial

Reimbursement Tutorial for GARDASIL

This print summary, designed for health care providers and their office staffs, contains information on coverage, coding, and reimbursement for GARDASIL. It was originally presented by Luis T. Gutierrez, Jr., President, Covance Commercialization Services. Mr. Gutierrez has in-depth knowledge of numerous medical technology markets, and regularly speaks to industry groups on health economic issues.

This tutorial is intended only for health care providers and their office staffs. It is not intended for use by patients and/or consumers.

Plan-Specific Information

Search for plan-specific information for GARDASIL by state and plan type.

Insurance Verification Checklist

Download the Insurance Verification Checklist (PDF) to help get information concerning a patient's insurance coverage for a specific product.

Reimbursement Claim Support Letters

To streamline your practice's reimbursement process, the Merck Vaccine Reimbursement Support Center provides you with sample advocacy letters concerning various reimbursement issues. Letters are customized by Merck product.

Product Denied Letter Reconsideration Letter Pre-certification Letter
GARDASIL®

[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]

GARDASIL Adult Reimbursement Denied Letter (PDF) GARDASIL Adult Reimbursement Reconsideration Letter (PDF) GARDASIL Pre-Certification Letter (PDF)

Request for Benefit Information

Use the Request for Benefit Information form to ask the Merck Vaccine Reimbursement Support Center to research patient-specific reimbursement issues directly with a third-party payer. This service is limited to five (5) patients per month, per office location.

GARDASIL is a registered trademark of Merck & Co., Inc.